| Literature DB >> 35733030 |
Hena Khandakar1, Shipra Agarwal2, Mehar Chand Sharma1, Devasenathipathy Kandasamy3, Chandrasekhar Bal4, Yashvant Rathode5, Rijuta Aphale5.
Abstract
Amphicrine phenotype in medullary thyroid carcinoma (MTC) is a rare phenomenon characterized by tumor cells that show both endocrine differentiation (calcitonin secretion) and exocrine differentiation (mucin production and secretion). Not much is known about the pathobiology of amphicrine MTCs. This report undertook a case-based review approach by discussing the cytological, histopathological, and ultrastructural features of this rare enigmatic entity, expanding on the radiological and novel MUC immunohistochemistry findings from a 28-year-old MEN2B syndrome patient with C cell hyperplasia and multifocal MTC with amphicrine features. The patient had widespread hematogenous metastases at presentation. MUC immunoexpression analysis revealed evidence of micro-lumina formation, and unique to-date unreported expression patterns of MUC1, MUC5AC, and MUC6 in an amphicrine subtype of MTC. Review of the literature identified five other MTC cases with well-documented amphicrine features. Of these six cases, two were associated with MEN2B syndrome, and four had metastatic disease. Follow-up was available in three patients, and two died of disease. Recognition of this rare subtype of MTC may be of clinical interest given their frequent link to MEN2B syndrome and biological aggressiveness.Entities:
Keywords: Amphicrine carcinoma; Amphicrine subtype medullary thyroid carcinoma; MEN2B syndrome; MUC1; MUC5AC; MUC6; Medullary thyroid carcinoma; MiNEN; RET; Radiology
Mesh:
Year: 2022 PMID: 35733030 DOI: 10.1007/s12022-022-09725-1
Source DB: PubMed Journal: Endocr Pathol ISSN: 1046-3976 Impact factor: 4.056